Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure.

Chun S, Tu JV, Wijeysundera HC, Austin PC, Wang X, Levy D, Lee DS.

Circ Heart Fail. 2012 Jul 1;5(4):414-21. doi: 10.1161/CIRCHEARTFAILURE.111.964791. Epub 2012 May 2.

2.

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B.

JACC Heart Fail. 2015 Jun;3(6):429-41. doi: 10.1016/j.jchf.2014.12.017. Epub 2015 May 14.

PMID:
25982110
3.

Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.

McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS; Cardiovascular Research Network PRESERVE Study..

J Am Heart Assoc. 2013 Feb 1;2(1):e005694. doi: 10.1161/JAHA.112.005694.

4.

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.

Khazanie P, Hellkamp AS, Fonarow GC, Bhatt DL, Masoudi FA, Anstrom KJ, Heidenreich PA, Yancy CW, Curtis LH, Hernandez AF, Peterson ED, Al-Khatib SM.

J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.

5.

Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.

McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ; HF-ACTION Investigators..

Clin Cardiol. 2013 Oct;36(10):611-20. doi: 10.1002/clc.22181. Epub 2013 Aug 8.

6.

Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure.

Habal MV, Liu PP, Austin PC, Ross HJ, Newton GE, Wang X, Tu JV, Lee DS.

Circ Heart Fail. 2014 Jan;7(1):12-20. doi: 10.1161/CIRCHEARTFAILURE.113.000429. Epub 2013 Dec 2.

7.

Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005.

Teng TH, Hung J, Knuiman M, Stewart S, Arnolda L, Jacobs I, Hobbs M, Sanfilippo F, Geelhoed E, Finn J.

Int J Cardiol. 2012 Jul 26;158(3):405-10. doi: 10.1016/j.ijcard.2011.01.061. Epub 2011 Feb 21.

PMID:
21334755
8.

Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure.

Kozdağ G, Yaymacı M, Ertaş G, Celikyurt U, Sahin T, Kılıç T, Ural D.

Heart Vessels. 2012 Nov;27(6):568-75. doi: 10.1007/s00380-011-0185-6. Epub 2011 Sep 10.

PMID:
21909806
9.

Predictors of cause-specific hospital readmission in patients with heart failure.

Babayan ZV, McNamara RL, Nagajothi N, Kasper EK, Armenian HK, Powe NR, Baughman KL, Lima JA.

Clin Cardiol. 2003 Sep;26(9):411-8.

10.

Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.

Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, Hsu G, Sung SH, Magid DJ, Go AS.

Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):333-42. doi: 10.1161/CIRCOUTCOMES.113.000221. Epub 2013 May 17.

11.

Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction.

Bello NA, Claggett B, Desai AS, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Solomon SD.

Circ Heart Fail. 2014 Jul;7(4):590-5. doi: 10.1161/CIRCHEARTFAILURE.113.001281. Epub 2014 May 29.

12.

In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.

Senni M, Gavazzi A, Oliva F, Mortara A, Urso R, Pozzoli M, Metra M, Lucci D, Gonzini L, Cirrincione V, Montagna L, Di Lenarda A, Maggioni AP, Tavazzi L; IN HF Outcome Investigators..

Int J Cardiol. 2014 May 1;173(2):163-9. doi: 10.1016/j.ijcard.2014.02.018. Epub 2014 Feb 22.

PMID:
24630337
13.

Stroke and Heart Failure: Clinical Features, Access to Care, and Outcomes.

Pongmoragot J, Lee DS, Park TH, Fang J, Austin PC, Saposnik G; Registry of the Canadian Stroke Network.; University of Toronto Stroke Program for the Stroke Outcomes Research Canada (SORCan—www.sorcan.ca) Working Group..

J Stroke Cerebrovasc Dis. 2016 May;25(5):1048-56. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.013. Epub 2016 Feb 4.

PMID:
26853141
14.

Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation.

Braga JR, Tu JV, Austin PC, Chong A, You JJ, Farkouh ME, Ross HJ, Lee DS.

Circ Heart Fail. 2013 Mar;6(2):193-202. doi: 10.1161/CIRCHEARTFAILURE.112.000075. Epub 2013 Feb 6.

15.

Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H; JCARE-CARD Investigators..

Circ J. 2009 Oct;73(10):1893-900. Epub 2009 Jul 31. Erratum in: Circ J. 2009 Dec;73(12):2365.

16.

Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure.

Lee DS, Ghosh N, Floras JS, Newton GE, Austin PC, Wang X, Liu PP, Stukel TA, Tu JV.

Circ Heart Fail. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCHEARTFAILURE.109.869743. Epub 2009 Sep 24.

17.

Prediction of 30-day heart failure-specific readmission risk by echocardiographic parameters.

Thavendiranathan P, Yingchoncharoen T, Grant A, Seicean S, Landers SH, Gorodeski EZ, Marwick TH.

Am J Cardiol. 2014 Jan 15;113(2):335-41. doi: 10.1016/j.amjcard.2013.09.025. Epub 2013 Oct 9.

PMID:
24268036
18.

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.

Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC.

Am Heart J. 2014 Nov;168(5):721-30. doi: 10.1016/j.ahj.2014.07.008. Epub 2014 Jul 22.

PMID:
25440801
19.

Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.

Hoong CW, Lim CP, Gao F, Chen Q, Kawa LB, Ching CK, Sim DK.

J Cardiovasc Med (Hagerstown). 2015 Sep;16(9):583-90. doi: 10.2459/JCM.0000000000000100. Review.

PMID:
25022929
20.

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie BM, Kitzman DW.

Circ Heart Fail. 2012 Sep 1;5(5):571-8. Epub 2012 Aug 10.

Supplemental Content

Support Center